Krishna Yeshwant
657842e515b5374051c373df Demis Hassabis Headshot 2023 new -p-1600

Isomorphic Labs is reimagining the entire drug discovery process from first principles with an AI-first approach.

Sector

Life Sciences

Date Invested

2025

Investor

Krishna Yeshwant (left)

First Round

Series A

Founder & CEO

Sir Demis Hassabis, PhD (right)